Acquired haemophilia and the New Oral Anticoagulants (NOACs): coincidence or drug‐induced adverse event?

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|6|e496-e497

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.6, 2015-11, pp. : e496-e497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 285-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Oral Anticoagulants and Their Reversal

By  

Current Drug Safety, Vol. 10, Iss. 3, 2015-01 ,pp. : 208-216

Bentham Science Publishers

Access to resources Recommend Favorite

Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1192-1200

John Wiley & Sons Inc

Access to resources Recommend Favorite

An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation

By Leigh J. Paul   White Richard H.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2071-2081

Informa Healthcare

Access to resources Recommend Favorite

Drug-induced oral mucous membrane pemphigoid: a case report

By Bercault Bastien   Fenelon Mathilde   Catros Sylvain   Marteau Jean-Marie   Fricain Jean-Christophe  

Médecine Buccale - Chirurgie Buccale, Vol. 23, Iss. 4, 2017-12 ,pp. : 181-183

Edp Sciences

Access to resources Recommend Favorite